Skip to content
BioCina
  • About Us
    • Our Company
      • About BioCina
      • Our History
      • Mission and Vision
      • Executive Leadership
    • Facilities
      • Adelaide
      • Perth
  • Our Services
    • Drug Substance Offerings
      • Microbial
      • pDNA
      • mRNA
      • LNP
    • Drug Product Offerings
      • Blow Fill Seal
      • Multi Format Vials
      • Cytotoxic / High Potency
      • Vials, Pre-filled Syringes (PFS), Cartridges
    • Services
      • Technology Transfer
      • Process Development
      • Analytical Development
      • cGMP Manufacturing
      • Sterile Filling
        • Clinical Trial Supply
        • Commercial Supply
        • Orphan Drug Manufacture
      • Quality & Regulatory
      • cGMP Warehousing
  • News, Insights & Resources
    • News
      • Press Releases
      • Events
    • Thought Leadership
      • Research
      • White Papers
    • Resources
      • Videos
      • Fact Sheets
      • Case Studies
  • Careers
    • Join Our Team
      • A Career at BioCina
      • Current Job Openings
  • Policies
    • Our Policies
      • Quality Policy
      • EHS Policy
      • Privacy Policy
  • Contact Us
BioCina

Cytotoxic / High Potency

As an end-to-end provider of pharmaceutical manufacturing solutions, BioCina is equipped to supply broad cytotoxic and potent drug production services. The highly sensitive and complex nature of manufacturing these compounds means only world-class facilities and experienced staff can be entrusted with their care. We have an unrivaled 30+ year track record for quality and safety and take the utmost care to prevent even the slightest oversight from compromising patients and caregivers, your reputation or business success.

BioCina offers multi-format dosing capabilities in ready-to-use plastic vials. Strong history of approvals and licenses to supply to over 70 countries

  • Ready-to-use liquid formulations in polypropylene plastic vials
  • Vial fill volumes range from 1mL to 100mL
  • Wide range of batch sizes from 15L to 1,180L
  • 5M+ unit capacity
  • Clear and amber vials
  • Aseptic and terminal sterilization
  • Filling of oxygen sensitive products

Oncology capabilities are delivered using:

  • Dedicated Oncology area (labs & manufacturing) is self-contained within the larger facility
  • Restricted Access Barrier System (RABS) filling lines
  • Complete visual inspection performed by highly trained operating personnel
  • 24×7 operating capacity (three shifts/day)

Comprehensive Services for Your Every Need

Quality and Regulatory Services BioCina

Quality &
Regulatory

We produce mRNA drug substance of the highest quality standards, in full compliance with all global regulatory requirements.

Read More
BioCina Process Development

Process
Development

BioCina’s expert Poly Nucleic Acid Products team is equipped to develop end-to-end mRNA manufacturing processes up to 1 L IVT and 1 L LNP encapsulation scale.

Read More
Analytical Development BioCina

Analytical
Development

Robust and compliant test methods are developed to ensure the quality, safety and efficacy of all products manufactured at BioCina.

Read More

cGMP
Manufacturing

End-to-end cGMP manufacturing of LNP encapsulated mRNA, including cell line development and cGMP manufacture of template plasmid DNA.

Read More

Technology
Transfer

Our highly structured approach, including comprehensive gap analysis and robust risk mitigation, ensures reliable technology and process transfers.

Read More

Our Expertise On Demand

Thought Leadership & Resources

BioCina and NovaCina Merger Bolsters Global CDMO Industry

January 13, 2025
|
Press Releases
BioCina Chief Executive Officer, Mark W. Womack BioCina Chief Executive Officer, Mark W. Womack [ADELAIDE, SOUTH...

BioCina Expands Perth Facility to Provide Clinical Supplies Services

November 17, 2024
|
Press Releases
BioCina Expands Perth Facility to Provide Clinical Supplies Services Exciting news from NovaCina!We’ve installed and qualified...
Centivax Selects Global CDMO BioCina to Initiate cGMP Manufacturing

Centivax Selects Global CDMO BioCina to Initiate cGMP Manufacturing of Revolutionary Universal Influenza Vaccine

October 10, 2024
|
Press Releases
Adelaide, South Australia, October 10, 2024/-- BioCina Pty Ltd., a global end-to-end biologics Contract Development and...

Let’s Work Together

Contact Us
  • About Us
    • Our Company
      • About BioCina
      • Our History
      • Mission and Vision
      • Executive Leadership
    • Facilities
      • Adelaide
      • Perth
  • Our Services
    • Drug Substance Offerings
      • Microbial
      • pDNA
      • mRNA
      • LNP
    • Drug Product Offerings
      • Blow Fill Seal
      • Multi Format Vials
      • Cytotoxic / High Potency
      • Vials, Pre-filled Syringes (PFS), Cartridges
    • Services
      • Technology Transfer
      • Process Development
      • Analytical Development
      • cGMP Manufacturing
      • Sterile Filling
        • Clinical Trial Supply
        • Commercial Supply
        • Orphan Drug Manufacture
      • Quality & Regulatory
      • cGMP Warehousing
  • News, Insights & Resources
    • News
      • Press Releases
      • Events
    • Thought Leadership
      • Research
      • White Papers
    • Resources
      • Videos
      • Fact Sheets
      • Case Studies
  • Careers
    • Join Our Team
      • A Career at BioCina
      • Current Job Openings
  • Policies
    • Our Policies
      • Quality Policy
      • EHS Policy
      • Privacy Policy
  • Contact Us
OUR VISION

To be the most client-centric and reliable CDMO, accelerating therapies to market and enriching the lives of all stakeholders.

 

OUR MISSION

We provide everything clients value the most.
We keep our commitments through unrivaled quality and industry-leading on-time and in-full delivery, every step of the way.

About Us

  • Our Company
  • About BioCina
  • Our History
  • Mission and Vision
  • Executive Leadership


  • Facilities
  • Adelaide
  • Perth
Our Services

  • Drug Substance Offerings
  • Microbial
  • pDNA
  • mRNA
  • LNP


  • Drug Product Offerings
  • Blow Fill Seal
  • Multi Format Vials
  • Cytotoxic / High Potency
  • Vials, Pre-filled Syringes (PFS), Cartridges


  • Services
  • Technology Transfer
  • Process Development
  • Analytical Development
  • cGMP Manufacturing
  • Sterile Filling
    • Clinical Trial Supply
    • Commercial Supply
    • Orphan Drug Manufacture
  • Quality & Regulatory
  • cGMP Warehousing
News, Insights & Resources

  • News
  • Press Releases
  • Events


  • Thought Leadership
  • Research
  • White Papers


  • Resources
  • Videos
  • Fact Sheets
  • Case Studies
Careers

  • Join Our Team
  • A Career at BioCina
  • Current Job Openings

Policies
  • Our Policies
  • Quality Policy
  • EHS Policy
  • Privacy Policy
Contact Us

© 2025 BioCina. All Rights Reserved.